Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?

Recent clinical, genetic and biochemical experimental evidences highlight the existence of common molecular pathways underlying neurodegenerative diseases. In this review, we will explore a key common pathological mechanism, i.e., the loss of neuroprotective factors, across the three major neurodege...

Full description

Bibliographic Details
Main Authors: Luisa Benussi, Giuliano Binetti, Roberta Ghidoni
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fnins.2017.00672/full
_version_ 1818615868011053056
author Luisa Benussi
Giuliano Binetti
Giuliano Binetti
Roberta Ghidoni
author_facet Luisa Benussi
Giuliano Binetti
Giuliano Binetti
Roberta Ghidoni
author_sort Luisa Benussi
collection DOAJ
description Recent clinical, genetic and biochemical experimental evidences highlight the existence of common molecular pathways underlying neurodegenerative diseases. In this review, we will explore a key common pathological mechanism, i.e., the loss of neuroprotective factors, across the three major neurodegenerative diseases leading to dementia: Alzheimer's disease (AD), Frontotemporal dementia (FTD) and Lewy body dementia (LBD). We will report evidences that the Brain Derived Neurotrophic Factor (BDNF), the most investigated and characterized brain neurotrophin, progranulin, a multi-functional adipokine with trophic and growth factor properties, and cystatin C, a neuroprotective growth factor, are reduced in AD, FTD, and LBD. Moreover, we will review the molecular mechanism underlying the loss of neuroprotective factors in neurodegenerative diseases leading to dementia, with a special focus on endo-lysosomal pathway and intercellular communication mediated by extracellular vesicles. Exploring the shared commonality of disease mechanisms is of pivotal importance to identify novel potential therapeutic targets and to develop treatments to delay, slow or block disease progression.
first_indexed 2024-12-16T16:40:44Z
format Article
id doaj.art-396b91dbf6e74233931c119f040d860e
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-16T16:40:44Z
publishDate 2017-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-396b91dbf6e74233931c119f040d860e2022-12-21T22:24:20ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2017-12-011110.3389/fnins.2017.00672312759Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?Luisa Benussi0Giuliano Binetti1Giuliano Binetti2Roberta Ghidoni3Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, ItalyMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, ItalyMAC Memory Center, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, ItalyMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, ItalyRecent clinical, genetic and biochemical experimental evidences highlight the existence of common molecular pathways underlying neurodegenerative diseases. In this review, we will explore a key common pathological mechanism, i.e., the loss of neuroprotective factors, across the three major neurodegenerative diseases leading to dementia: Alzheimer's disease (AD), Frontotemporal dementia (FTD) and Lewy body dementia (LBD). We will report evidences that the Brain Derived Neurotrophic Factor (BDNF), the most investigated and characterized brain neurotrophin, progranulin, a multi-functional adipokine with trophic and growth factor properties, and cystatin C, a neuroprotective growth factor, are reduced in AD, FTD, and LBD. Moreover, we will review the molecular mechanism underlying the loss of neuroprotective factors in neurodegenerative diseases leading to dementia, with a special focus on endo-lysosomal pathway and intercellular communication mediated by extracellular vesicles. Exploring the shared commonality of disease mechanisms is of pivotal importance to identify novel potential therapeutic targets and to develop treatments to delay, slow or block disease progression.http://journal.frontiersin.org/article/10.3389/fnins.2017.00672/fullBDNFprogranulincystatin Cbiomarkersfrontotemporal dementiaAlzheimer's disease
spellingShingle Luisa Benussi
Giuliano Binetti
Giuliano Binetti
Roberta Ghidoni
Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
Frontiers in Neuroscience
BDNF
progranulin
cystatin C
biomarkers
frontotemporal dementia
Alzheimer's disease
title Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
title_full Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
title_fullStr Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
title_full_unstemmed Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
title_short Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
title_sort loss of neuroprotective factors in neurodegenerative dementias the end or the starting point
topic BDNF
progranulin
cystatin C
biomarkers
frontotemporal dementia
Alzheimer's disease
url http://journal.frontiersin.org/article/10.3389/fnins.2017.00672/full
work_keys_str_mv AT luisabenussi lossofneuroprotectivefactorsinneurodegenerativedementiastheendorthestartingpoint
AT giulianobinetti lossofneuroprotectivefactorsinneurodegenerativedementiastheendorthestartingpoint
AT giulianobinetti lossofneuroprotectivefactorsinneurodegenerativedementiastheendorthestartingpoint
AT robertaghidoni lossofneuroprotectivefactorsinneurodegenerativedementiastheendorthestartingpoint